In Vitro Assays for Comparing the Specificity of First- and Next-Generation CRISPR/Cas9 Systems

Sep 14, 2020Methods in molecular biology (Clifton, N.J.)

Lab tests comparing how precisely first- and next-generation CRISPR/Cas9 systems target genes

AI simplified

CRISPR Gene Editing on OpenScience ↗PubMed ↗DOI ↗

Abstract

Two in vitro methods are presented to compare the specificity of first- and next-generation CRISPR/Cas9 systems.

The methods allow for evaluation of the specificity of different guide RNA/Cas9 complexes on known off-target DNA sequences.
One assay provides a broad specificity profile by assessing cleavage across a large library of potential off-target DNA sequences.
These assays may facilitate the assessment of CRISPR/Cas9 systems on any DNA target sequence efficiently.
Improved specificity in CRISPR/Cas9 systems could help mitigate concerns regarding off-target effects in genetic therapies.

AI simplified

CRISPR/Cas9 has revolutionized the ability to edit cellular DNA and is poised to transform the treatment of genetic diseases. One of the major concerns regarding its therapeutic use is the potential for off-target DNA cleavage, which could have detrimental consequences in vivo. To circumvent this, a number of strategies have been employed to develop next-generation CRISPR/Cas9 systems with improved specificity. These include the development of new protein variants of Cas9, as well as chemically modified guide RNA molecules. Here, we provide detailed protocols for two in vitro methods that enable the specificity of first- and next-generation CRISPR/Cas9 systems to be compared, and we demonstrate their applicability to evaluating chemically modified guide RNAs. One of these assays allows the specificity of different guide RNA/Cas9 complexes to be compared on a set of known off-target DNA sequences, while the second provides a broad specificity profile based on cleavage of a massive library of potential off-target DNA sequences. Collectively, these assays may be used to evaluate the specificity of different CRISPR/Cas9 systems on any DNA target sequence in a time- and cost-effective manner.

Full Text

Full text is available at the source.

View full text ↗

In Vitro Assays for Comparing the Specificity of First- and Next-Generation CRISPR/Cas9 Systems

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the crispr gene editing brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the crispr gene editing brief